- Article
Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro
- Antonio Fernando Leis-Filho,
- Patrícia de Faria Lainetti,
- Priscila Emiko Kobayashi,
- Carlos Eduardo Fonseca-Alves and
- Renée Laufer-Amorim
HER2 is a prognostic and predictive marker widely used in breast cancer. Lapatinib is a tyrosine kinase inhibitor that works by blocking the phosphorylation of the receptor HER2. Its use is related to relatively good results in the treatment of women...

